< Back to previous page
Researcher
Karin Thevissen
- Disciplines:Infectious diseases, Mycology
Affiliations
- Microbial and Plant Genetics (CMPG) (Division)
Member
From1 Aug 2020 → Today - Centre of Microbial and Plant Genetics (Division)
Member
From1 Aug 2005 → 31 Jul 2020
Projects
1 - 10 of 27
- PHGDH-ASM: Phosphoglycerate dehydrogenase (PHGDH) activators as novel antiseizure medications (ASM) with dual mode of actionFrom1 Oct 2022 → TodayFunding: IOF - technology validation in lab
- Targeting intestinal macrophages as new treatment for Inflammatory Bowel Disease. IBD-MAC.From1 Oct 2021 → 30 Sep 2023Funding: IOF - technology validation in lab
- Sustainable development of a safe & biobased Antimicrobial, Antifungal and Antiviral nanoCOATing platformFrom1 Jun 2021 → 31 May 2023Funding: BOF - various
- Dual-band fibered confocal fluorescence microscope for the intravital interrogation of deep tissues and organs in real time and with cellular resolutionFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Repurposing of existing chemicals as inducers of plant resistance for a more sustainable agriculture.From27 Aug 2019 → 27 Aug 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- ‘Bisceps’ Biofilm susceptibility sensors for in situ biofilm monitoring.From1 Jan 2019 → 31 Dec 2022Funding: FWO Strategic Basic Research (SBO)
- Preclinical characterization of miconazole potentiators as novel treatment of biofilm-related infections and epilepsyFrom1 Jan 2018 → 29 Sep 2021Funding: BOF - doctoral mandates
- In vivo validation of the resistance-proof activity of 2-aminoimidazole based anti-biofilm coatings for medical implantsFrom1 Oct 2017 → 30 Sep 2019Funding: IOF - Industrial Research Fund
- iDAIpps: Indwelling device associated infections: pathology and preventive solutions.From15 Jul 2017 → 14 Jul 2019Funding: BOF - Bilateral scientific cooperation
- Metabolic rewiring in cancer: Pharmacological targeting of serine/glycine synthesis addicted cancersFrom24 May 2017 → 15 Dec 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
31 - 40 of 146
- An antibiofilm coating of 5-aryl-2-aminoimidazole covalently attached to a titanium surface(2019)
Authors: Elien Peeters, Geert Hooyberghs, Annabel Braem, Birgit Claes, Jef Vleugels, Bruno Cammue, Karin Thevissen, Patrick Van Dijck, Jos Vanderleyden, Erik Van der Eycken, et al.
Pages: 1908 - 1919 - Polylactic acid (PLA): novel approaches for synthesis and functionalization(2019)
Authors: Sofie Winderickx, Bruno Cammue, Karin Thevissen
- Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33(2018)
Authors: Sofie Winderickx, Matthew Bird, Bruno Cammue, Karin Thevissen
Pages: 33 - 38 - Polyastaxanthin-based coatings reduce bacterial colonization in vivo(2018)
Authors: Karin Thevissen
Pages: 15 - 20 - Methodologies for invitro and invivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms(2018)
Authors: Patrick Van Dijck, Bruno Cammue, Katrien Lagrou, Johan Maertens, Isabel Spriet, Joost Wauters, Karin Thevissen
Pages: 300 - 326 - In vitro methods for the evaluation of antimicrobial surface designs(2018)
Authors: Karin Thevissen
Pages: 12 - 24 - Regulated Cell Death as a Therapeutic Target for Novel Antifungal Peptides and Biologics(2018)
Authors: Karin Thevissen
- Guidelines and recommendations on yeast cell death nomenclature(2018)
Authors: Johan Thevelein, Karin Thevissen, Joris Winderickx
Pages: 4 - 31 - From Regulated Cell Death to Adaptive Stress Strategies: Convergence and Divergence in Eukaryotic Cells(2018)
Authors: Karin Thevissen
- Exploring the potential of plant defensins as basis for diagnosis and treatment of fungal diseases(2017)
Authors: Tanne Cools, Bruno Cammue, Karin Thevissen
Patents
1 - 10 of 10
- Idebenone in the treatment of drug resistant epilepsy (Inventor)
- Compositions against candida infections (Inventor)
- Treatment of epilepsy (Inventor)
- Compositions against candida infections (Inventor)
- Pharmacological targeting of de novo serine/glycine synthesis (Inventor)
- Compositions against candida infections (Inventor)
- Compositions and methods for treating biofilms (Inventor)
- Agents for increased resistance against oxidative stress conditions (Inventor)
- ANTIFUNGAL COMPOUNDS (Inventor)
- ANTIMICROBIAL PEPTIDES (Inventor)